$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

$sfes Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000008611517000093 Filed on July 27, 2017

Income Statement

Concept	2017 Q2	2016 Q2
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$4.500M	$4.800M
YoY Change	-6.25%	0.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$4.600M	$4.800M
YoY Change	-4.17%	0.0%
Operating Profit	-$4.486M	-$4.849M
YoY Change	-7.49%	2.0%
Interest Expense	-$24.50M	$43.20M
YoY Change	-156.71%	-402.1%
% of Operating Profit
Other Income/Expense, Net	-$89.00K	$659.0K
YoY Change	-113.51%	-4493.33%
Pretax Income	-$29.10M	$38.98M
YoY Change	-174.65%	-304.9%
Income Tax	$0.00	$0.00
% Of Pretax Income		0.0%
Net Earnings	-$29.10M	$38.98M
YoY Change	-174.65%	-304.9%
Net Earnings / Revenue
Basic Earnings Per Share	-$1.43	$1.92
Diluted Earnings Per Share	-$1.43	$1.70
COMMON SHARES
Basic Shares Outstanding	20.41M shares	20.33M shares
Diluted Shares Outstanding	20.41M shares	23.54M shares

Balance Sheet

Concept	2017 Q2	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$53.60M	$80.70M
YoY Change	-33.58%	-10.43%
Cash & Equivalents	$48.20M	$66.23M
Short-Term Investments	$5.400M	$14.50M
Other Short-Term Assets	$3.300M	$2.300M
YoY Change	43.48%	-4.17%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$56.23M	$83.04M
YoY Change	-32.28%	-10.28%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.705M	$2.055M
YoY Change	-17.03%	517.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$119.0M	$158.4M
YoY Change	-24.92%	8.56%
Other Assets	$316.0K	$992.0K
YoY Change	-68.15%	-49.8%
Total Long-Term Assets	$157.1M	$192.6M
YoY Change	-18.46%	-0.22%
TOTAL ASSETS
Total Short-Term Assets	$56.23M	$83.04M
Total Long-Term Assets	$157.1M	$192.6M
Total Assets	$213.3M	$275.7M
YoY Change	-22.62%	-3.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$151.0K	$155.0K
YoY Change	-2.58%	-34.87%
Accrued Expenses	$1.942M	$2.550M
YoY Change	-23.84%	1.51%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$42.30M
YoY Change
Total Short-Term Liabilities	$47.04M	$5.261M
YoY Change	794.16%	1.19%
LONG-TERM LIABILITIES
Long-Term Debt	$44.50M	$51.70M
YoY Change	-13.93%	1.17%
Other Long-Term Liabilities	$3.580M	$4.010M
YoY Change	-10.72%	15.53%
Total Long-Term Liabilities	$3.580M	$4.010M
YoY Change	-10.72%	15.53%
TOTAL LIABILITIES
Total Short-Term Liabilities	$47.04M	$5.261M
Total Long-Term Liabilities	$3.580M	$4.010M
Total Liabilities	$95.14M	$61.01M
YoY Change	55.93%	2.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$678.1M	-$581.1M
YoY Change	16.69%	0.47%
Common Stock	$816.9M	$819.8M
YoY Change	-0.35%	-0.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$20.28M	$23.76M
YoY Change	-14.66%	32.18%
Treasury Stock Shares	1.169M shares	1.351M shares
Shareholders Equity	$118.2M	$214.7M
YoY Change
Total Liabilities & Shareholders Equity	$213.3M	$275.7M
YoY Change	-22.62%	-3.48%

Cashflow Statement

Concept	2017 Q2	2016 Q2
OPERATING ACTIVITIES
Net Income	-$29.10M	$38.98M
YoY Change	-174.65%	-304.9%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$4.900M	-$5.000M
YoY Change	-2.0%	6.38%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$100.0K
YoY Change	-100.0%	0.0%
Acquisitions
YoY Change
Other Investing Activities	-$10.00M	$43.50M
YoY Change	-122.99%	-325.39%
Cash From Investing Activities	-$10.00M	$43.40M
YoY Change	-123.04%	-322.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	32.50M	-300.0K
YoY Change	-10933.33%
NET CHANGE
Cash From Operating Activities	-4.900M	-5.000M
Cash From Investing Activities	-10.00M	43.40M
Cash From Financing Activities	32.50M	-300.0K
Net Change In Cash	17.60M	38.10M
YoY Change	-53.81%	-257.44%
FREE CASH FLOW
Cash From Operating Activities	-$4.900M	-$5.000M
Capital Expenditures	$0.00	-$100.0K
Free Cash Flow	-$4.900M	-$4.900M
YoY Change	0.0%	6.52%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000086115
CY2017Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20413316	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	SAFEGUARD SCIENTIFICS INC
	dei	Trading Symbol TradingSymbol	SFE
CY2017Q2	sfe	Cash Cash Equivalents And Marketable Securities CashCashEquivalentsAndMarketableSecurities	53600000	USD
CY2015Q4	sfe	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents CashCashEquivalentsRestrictedCashandRestrictedCashEquivalents	32838000	USD
CY2016Q2	sfe	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents CashCashEquivalentsRestrictedCashandRestrictedCashEquivalents	66231000	USD
CY2016Q4	sfe	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents CashCashEquivalentsRestrictedCashandRestrictedCashEquivalents	28394000	USD
CY2017Q2	sfe	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents CashCashEquivalentsRestrictedCashandRestrictedCashEquivalents	54517000	USD
	sfe	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	33393000	USD
	sfe	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	26123000	USD
CY2017Q2	sfe	Cash Liabilityfor Performance Based Units CashLiabilityforPerformanceBasedUnits	0	USD
CY2001Q4	sfe	Future Annual Payment To Chairman And Chief Executive Officer FutureAnnualPaymentToChairmanAndChiefExecutiveOfficer	650000	USD
CY2016Q2	sfe	Other Comprehensive Income Loss Reclassification Adjustmenton Saleof Equity Method Investments OtherComprehensiveIncomeLossReclassificationAdjustmentonSaleofEquityMethodInvestments	0	USD
	sfe	Other Comprehensive Income Loss Reclassification Adjustmenton Saleof Equity Method Investments OtherComprehensiveIncomeLossReclassificationAdjustmentonSaleofEquityMethodInvestments	0	USD
CY2017Q2	sfe	Other Comprehensive Income Loss Reclassification Adjustmenton Saleof Equity Method Investments OtherComprehensiveIncomeLossReclassificationAdjustmentonSaleofEquityMethodInvestments	0	USD
	sfe	Other Comprehensive Income Loss Reclassification Adjustmenton Saleof Equity Method Investments OtherComprehensiveIncomeLossReclassificationAdjustmentonSaleofEquityMethodInvestments	50000	USD
CY2016Q2	sfe	Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments	20000	USD
	sfe	Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments	10000	USD
CY2017Q2	sfe	Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments	5000	USD
	sfe	Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments	3000	USD
CY2017Q2	sfe	Partner Companies Not Consolidated In Financial Statements PartnerCompaniesNotConsolidatedInFinancialStatements	28	nonconsolidated_partner_company
CY2017Q2	sfe	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Award Vesting Types SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofAwardVestingTypes	2	vesting_type
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	140000	USD
CY2017Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	151000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2223000	USD
CY2017Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1942000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-431000	USD
CY2017Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-378000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	816016000	USD
CY2017Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	814767000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	246000	USD
CY2016Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	25142000	USD
CY2017Q2	us-gaap	Advances To Affiliate AdvancesToAffiliate	25050000	USD
CY2016Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	467000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1275000	USD
CY2017Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	351000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	246000	USD
CY2016Q4	us-gaap	Assets Assets	231828000	USD
CY2017Q2	us-gaap	Assets Assets	213308000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	32551000	USD
CY2017Q2	us-gaap	Assets Current AssetsCurrent	56233000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22058000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48181000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48200000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2017Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000	shares
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21573000	shares
CY2017Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21573000	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	2157000	USD
CY2017Q2	us-gaap	Common Stock Value CommonStockValue	2157000	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	38996000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	23534000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-29092000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-51141000	USD
CY2016Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	USD
CY2017Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	42320000	USD
CY2016Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	52560000	USD
CY2017Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	USD
CY2016Q4	us-gaap	Cost Method Investments CostMethodInvestments	3662000	USD
CY2017Q2	us-gaap	Cost Method Investments CostMethodInvestments	4021000	USD
CY2016Q2	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	1119000	USD
	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	2229000	USD
CY2017Q2	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	USD
	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	USD
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.92
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.15
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.43
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.51
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.70
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.09
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.43
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.51
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3498000	USD
CY2017Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2629000	USD
CY2016Q4	us-gaap	Equity Method Investments EquityMethodInvestments	154666000	USD
CY2017Q2	us-gaap	Equity Method Investments EquityMethodInvestments	118958000	USD
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4849000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10077000	USD
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4486000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9433000	USD
CY2016Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	8384000	USD
CY2017Q2	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	4733000	USD
CY2016Q4	us-gaap	Held To Maturity Securities Noncurrent HeldToMaturitySecuritiesNoncurrent	7302000	USD
CY2017Q2	us-gaap	Held To Maturity Securities Noncurrent HeldToMaturitySecuritiesNoncurrent	689000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	38976000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	23524000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-29097000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-51194000	USD
CY2016Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	43794000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	34299000	USD
CY2017Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-23497000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-40499000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	24000	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	22000	shares
CY2017Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2016Q2	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	148000	shares
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	155000	shares
CY2017Q2	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	0	shares
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	0	shares
CY2016Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	3034000	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	3034000	shares
CY2017Q2	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2016Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	1155000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	2304000	USD
CY2017Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	2112000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	3310000	USD
CY2016Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	527000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	947000	USD
CY2017Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1087000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1888000	USD
CY2016Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	183470000	USD
CY2017Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	148029000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	62051000	USD
CY2017Q2	us-gaap	Liabilities Liabilities	95136000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	231828000	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	213308000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5861000	USD
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	47042000	USD
CY2016Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	0	USD
CY2017Q2	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	44514000	USD
CY2017Q2	us-gaap	Marketable Securities MarketableSecurities	5400000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5744000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	32390000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	49980000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5140000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10843000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11407000	USD
CY2016Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	40095000	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	25753000	USD
CY2017Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-29097000	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-51194000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4849000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10077000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4486000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9433000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	296000	USD
CY2017Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	316000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	53000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3630000	USD
CY2017Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3580000	USD
CY2016Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	659000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	659000	USD
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-89000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	160000	USD
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	10151000	USD
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	13564000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5389000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5696000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	355000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	130000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	28329000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	8026000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	14604000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	73000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	0	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2017Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2109000	USD
CY2017Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3319000	USD
	us-gaap	Proceeds From Collection Of Advance To Affiliate ProceedsFromCollectionOfAdvanceToAffiliate	56000	USD
	us-gaap	Proceeds From Collection Of Advance To Affiliate ProceedsFromCollectionOfAdvanceToAffiliate	0	USD
	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	72824000	USD
	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	16462000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	12000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	50000000	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	30257000	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	10268000	USD
CY2016Q2	us-gaap	Profit Loss ProfitLoss	38976000	USD
	us-gaap	Profit Loss ProfitLoss	23524000	USD
CY2017Q2	us-gaap	Profit Loss ProfitLoss	-29097000	USD
	us-gaap	Profit Loss ProfitLoss	-51194000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1873000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1705000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	11796000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	6336000	USD
CY2017Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	6336000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-626904000	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-678098000	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	-677000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-45000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	169777000	USD
CY2017Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	118172000	USD
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1209000	shares
CY2017Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	1169000	shares
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	21061000	USD
CY2017Q2	us-gaap	Treasury Stock Value TreasuryStockValue	20276000	USD
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23539000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23602000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20411000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20395000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20333000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20391000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20411000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20395000	shares

Files In Submission

Name	View Source	Status
0000086115-17-000093-index-headers.html	Edgar Link	pending
0000086115-17-000093-index.html	Edgar Link	pending
0000086115-17-000093.txt	Edgar Link	pending
0000086115-17-000093-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sfe-20170630.xml	Edgar Link	completed
sfe-20170630.xsd	Edgar Link	pending
sfe-20170630_cal.xml	Edgar Link	unprocessable
sfe-20170630_def.xml	Edgar Link	unprocessable
sfe-20170630_lab.xml	Edgar Link	unprocessable
sfe-20170630_pre.xml	Edgar Link	unprocessable
sfe-2017xq2.htm	Edgar Link	pending
sfe-2017xq2xex311.htm	Edgar Link	pending
sfe-2017xq2xex312.htm	Edgar Link	pending
sfe-2017xq2xex321.htm	Edgar Link	pending
sfe-2017xq2xex322.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

2017 Q2 Form 10-Q Financial Statement

#000008611517000093 Filed on July 27, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES SAFEGUARD SCIENTIFICS INC Stock $sfes

2017 Q2 Form 10-Q Financial Statement

#000008611517000093 Filed on July 27, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes